Adverse effect of oth estrogens and progestogens, subs

This code signifies a harmful or undesirable reaction experienced by a patient due to the therapeutic use of estrogen or progestogen medications, occurring during a follow-up visit. These adverse effects are not due to poisoning, underdosing, or intentional self-harm.

Apply this code when documenting a patient's return visit for ongoing management or evaluation of an adverse reaction to prescribed estrogen or progestogen. This includes scenarios such as persistent nausea, headaches, or skin rashes attributed to these hormone therapies, after the initial treatment for the adverse effect has begun.

• Always sequence this code after the code for the specific adverse effect (e.g., R11.0 for nausea).
• Ensure documentation clearly links the adverse effect to the estrogen or progestogen medication.
• The "D" seventh character indicates a subsequent encounter, meaning the patient is receiving routine care during the healing or recovery phase of the adverse effect.